Page last updated: 2024-08-24

valsartan and Carcinoma, Epidermoid

valsartan has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tchernev, G1
Han, Q; Lei, J; Liao, YD; Wang, ZH; Xu, H; Zhang, YY1

Other Studies

2 other study(ies) available for valsartan and Carcinoma, Epidermoid

ArticleYear
NITROSOGENESIS LESSONS FROM DERMATOLOGISTS-NITROSAMINES/ NDSRIS CONTAMINATION OF THE POLIMEDICATION IN POLIMORBID PATIENTS AS THE MOST POWERFUL SKIN CANCER INDUCTOR: DOUBLE HATCHET FLAP FOR SCC OF THE SCALP OCCURRING DURING TREATMENT WITH VALSARTAN/ HYDRO
    Georgian medical news, 2023, Issue:342

    Topics: Aged, 80 and over; Carcinogens; Carcinoma, Squamous Cell; Dermatologists; Humans; Hydrochlorothiazide; Nitrosamines; Quality of Life; Scalp; Skin Neoplasms; Valsartan

2023
[Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Staging; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Valine; Valsartan; Vascular Endothelial Growth Factor A

2007